Abstract Submission

Submit Your Abstract Today




Thank you for your interest in submitting an abstract of original research for presentation as a virtual paper or poster at the AGS 2024 Virtual Annual Meeting. The abstract submission site will open on September 25, 2023.


All abstracts must be submitted online - hard copy abstract submission will not be accepted. The abstract submission deadline is December 1 at 11:59 pm Eastern Time (8:59 pm Pacific Time). The abstract submission fee is $40 per abstract payable by credit card. Visa, MasterCard and American Express are accepted. This charge will appear on your statement as "AGS".

Submission of an abstract does not constitute registration for the AGS annual meeting. Authors of accepted abstracts are expected to register for the meeting and pay the meeting registration fee.

Notification of the Abstract Selection Committee's decision will be made in February 2024. Abstracts accepted for presentation at the AGS 2024 Virtual Annual Meeting will be published in the Journal of the American Geriatrics Society exactly as they are submitted.

Abstract Content and Format 

Scientific abstracts report the results of original research and must contain data (either quantitative or qualitative) and report research results.

Abstract Body:

The abstract should conform to the following organization and contain: 

Background:    should describe the context and importance of the study and state the objective(s) of the study.

Methods:     should include a description of the methods used considering study design, setting, population, measures, and analytic procedures.

Results:     should describe the results in sufficient detail to support the conclusions. Tabular or graphic results are acceptable. It is not satisfactory to state, "The results will be discussed" or "Other data will be presented”.  Abstracts that do not provide actual results will not be considered for publication or presentation. Include any data on the racial/ethnic diversity of your research population in this section. 

Conclusions:    should state the implications of the findings for clinical practice, research, education, or policy.

Scientific abstracts that do not describe research methods and present study results will not be considered for presentation at the annual meeting. Statements such as "data will be presented" or "results will be shown" should not be included in submitted abstracts. Abstracts should include only nonproprietary (generic) names, which should be written in lowercase letters, e.g. acetaminophen.

ABSTRACT LIMIT: There are no restrictions on the number of abstracts you may submit. If more than two abstracts are accepted from one investigator, one of the co-authors should make any additional presentation.

CHARACTER LIMIT: There is a limit of 2650 characters for the text of your abstract submission. This includes title, authors, institutions, references and abstract body, as well as all spaces. 

TABLES and GRAPHICS: You may elect to submit either a table or an image, but not both. If you chose to submit a table, each row in the table will count as 50 characters. Image character count deduction is based on image size. The maximum deduction for an image is approximately 1200 characters. Images and tables can be easily edited or deleted any time before the submission deadline.

ABSTRACT PROOF: Proofing your abstract carefully is your responsibility. If accepted, the abstract will be published exactly as it is submitted - changes to the abstract will not be allowed once it has been submitted. Make sure all special characters and formatting are displaying properly in your proof. If you find errors, return to the appropriate page by clicking on the page name in the sidebar menu, and make your corrections.

In response to the ethical and scientific imperatives of inclusivity in research and to mitigate disparities in research participation and health, AGS has set a ten-year goal to ensure that all human subject research presented at the annual meeting and published in the JAGS is mindful of factors that may present vulnerability to exclusion and disparity.  We seek to understand and promote greater inclusivity, as well as ensure attention to scientific and clinical implications that associate with the representativeness of research presented, as well as the specific needs and health outcomes of under-represented, disproportionately affected, and understudied sub-populations. These factors include, but are not limited to, self-identified race/ethnicity, gender identity/expression, sexual orientation, age, functional impairment, English-language ability, and immigration status. While heterogeneity within and across these sub-groups is substantial, they are commonly referred to as “underrepresented, disproportionately affected, and understudied” populations. For the 2024 AGS Annual Meeting Abstract Submission process, we are including the series of questions below to better understand the current state of inclusivity in the research that is being presented.  We aim to learn from this to inform future initiatives to enhance inclusivity in research presented at AGS meetings. 

While answering these questions is required for your abstract to be reviewed, responses are not factored into your abstract score.

Please know that, with few exceptions, we will be asking authors whose work has been accepted to our meeting to report information on inclusion of underrepresented, disproportionately affected, and understudied populations in their posters and papers.  We recognize that not all work may include such data. Abstract submitters will have to answer the following questions:

1.    Approximately what percentage of the study sample represents participants from underrepresented, disproportionately affected, and understudied populations (e.g., Black or African American, Hispanic or Latino, Asian, American Indian and Alaska Native, Native Hawaiian and Other Pacific Islander, More than One Race, LGBTQ+, Persons with Disabilities).
___ % (options: 0-100 in increments of 5)
___ This information was not collected
___ This information was not available

a) If % is zero, are you reporting secondary data analyses (not involved in original study development)?
___ Yes
___ No

b) If you were involved in study development, describe what you did to include study participants from underrepresented, disproportionately affected, and understudied populations in your research and the barriers you faced:
[Open text box, 250 Character limit]

2.    Does your abstract include data from persons that identify as historically excluded and minoritized racial or ethinic groups (Black or African American, Hispanic or Latino, Asian, American Indian and Alaska Native, Native Hawaiian and Other Pacific Islander, More than One Race)?  
___ Yes  
___ No  
___ Not Collected

3.    Does your abstract include data from persons that identify as underrepresented/disproportionately affected/understudied gender identities (non-binary, transgender)?  
___ Yes  
___ No  
___ Not Collected

4.    Does your abstract include data from persons that identify as women?  
___ Yes  
___ No  
___ Not Collected

5.    Does your abstract include data from persons that identify as underrepresented/disproportionately affected/understudied sexual orientations (gay, lesbian, bisexual)?  
___ Yes  
___ No 
___ Not Collected

6.    Does your abstract include data on persons with functional impairment?  
___ Yes 
___ No  
___ Not Collected

7.    Does your abstract stratify the ages of your study population? 
___ Yes 
___ No  
             ___ Not Collected

Scientific abstract submissions must identify a primary submission category.

Case Series & Case Studies 
Scholarship using individual cases or case series to provide insight into best practices in geriatrics.

Clinical Innovation 
Research on evaluations and interventions in the clinical setting that exemplify translation of evidence from research to clinical practice and implementation science.

Clinical Trials 
Research testing interventions using random or non-random control / comparison groups. 

Descriptive studies of health and disease across large populations. 

Ethics & Qualitative Research 
Research exploring ethical and humanistic aspects of healthcare. 

Geriatric Bioscience 
Animal or human research examining fundamental biology of aging and / or disease processes.

Geriatric Education 
Research and evaluation of innovation in health education.

Geriatric Medicine in Other Specialties  
Research on care and outcomes in Emergency Medicine, Surgery, Rehabilitation, or other specialties working with geriatric populations. 

Geriatric Syndromes 
Descriptive research on the mechanisms, natural history or management of major geriatric syndromes. 

Health Services & Policy Research 
Research on healthcare delivery, policy and payment. 

Neurologic & Behavioral Science 
Research on neurologic or psychiatric conditions affecting older patients. 

Quality Measurement & Quality Improvement
Research on the evaluation of health care through quality measurement and standardized processes that produce a clinical structure which reduces related variability in outcomes and improve clinical care.

Presentation of original research findings is an important component of the American Geriatrics Society's Annual Scientific Meeting. Abstracts reporting results from original research studies will be reviewed by the Research Committee. Abstracts that are selected will be presented in poster and oral paper sessions devoted to original research.

By submitting an abstract for consideration, all authors must affirm the following:

  • I understand that submission of an abstract constitutes a commitment to present if accepted and that failure to present, if not justified, will jeopardize future acceptance of abstracts.
  • I understand that if accepted, the paper or poster abstract presentation must be made by one of the authors involved in the research and named as an author on the abstract. 
  • I understand that if more than two abstracts are accepted from an investigator, one of the co-authors must make any additional presentation.
  • I affirm that this abstract does not duplicate other research I have submitted.
  • I affirm that this research will not be published before the 2024 AGS annual meeting.
  • I affirm that this abstract complies with the principles set forth in DHHS Code of Federal Regulations #45 CFR 46 on Protection of Human Subjects.
  • I affirm that this abstract complies with the guidelines of the American Association for the Advancement for Science in requiring assurances of the responsible use of animals in research (American Association for the Advancement of Science. Resolutions on Use of Animals in Research, Testing, and Education. Adopted by the AAAS Board and Council, February 19, 1990).
  • I affirm that this abstract complies with the guidelines of the International Committee of Medical Journal Editors regarding publication ethics (International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Ann Intern Med. 1997; 126:36-47). In particular, I affirm that "all persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content. Authorship credit is based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Conditions 1, 2, and 3 are met for all authors".
  • I affirm that I have disclosed all funding in support of this research at the time of my submission and understand that the AGS will publish a statement regarding support of my research in the abstract book.

If accepted to present this research, I agree to disclose sources of funding at the time of presentation either in print (posters) or on a slide (oral paper presentations).

I affirm that submitted abstracts include only generic names and that should it be accepted, the poster or paper presentation will also use only generic names when discussing drug therapies.

Encore Presentations

The AGS invites encore presentations of research that has already been presented at other national or international meetings. Encore presentations of research should not have been published in anything other than abstract form before the 2024 AGS annual meeting. Please note that if you are applying for the New Investigator Award, you can not submit an encore presentation.

I affirm that if this abstract is an encore presentation, the research will not have been published in anything other than abstract form in advance of the AGS 2024 Annual Meeting.

Violation of these Guidelines
I am aware that violation of these submission guidelines may result in: 

  • a retraction withdrawing the abstract and detailing the reasons for its withdrawal being published in JAGS 
  • me and any industry supporter being prohibited from submitting an abstract for the next Annual Meeting, and a communications company organizing the submission being prohibited from participating in the next two annual meetings. 
  • potential imposition of a $5000 fine on any industry supporter for each abstract that violates any of the submission guidelines. 

Copyright Transfer

All authors must agree to transfer to the American Geriatrics Society the copyright and all other rights in the material comprising the abstract if the abstract is accepted. Authors with exceptions that will not allow them to agree to the transfer of the copyright (e.g. U.S. Government employees) should note the reason for not agreeing to the transfer of the copyright.


Abstract Selection Committee members Camille P. Vaughan, MD, MS, and Cathleen Colon-Emeric, MD, FACP, MHSc, AGSF, developed a webinar in 2018 on preparing and writing abstracts for presentation at the AGS Annual Scientific Meeting.  The content on this webinar is evergreen, so we encourage you to watch it to learn how to write a research abstract that will be accepted for presentation. The abstract drafting process takes time and effort. It's a skill that can be learned, however, and it's a skill that also will increase the likelihood your research will be accepted for presentation at #AGS23. Drs. Vaughn and Colon-Emeric will focus on how to write a solid abstract, what reviewers look for when reviewing abstracts, and how to navigate the basics of the abstract submission website. 

Click HERE to view the webinar.  You can also access the webinar by going to GCO and using the search box to look for the key words “research abstract”.